COVID-19 vaccines no longer will be recommended for healthy children or healthy women who are pregnant, according to Health and Human Services secretary Robert F. Kennedy, Jr. This policy change has been strongly criticized by medical groups. It contradicts existing evidence about the safety and efficacy of the vaccines and could further erode public trust in preventive medicine. Moreover, this decision could reduce vaccine access at a time when a potentially dangerous new SARS-CoV-2 variant, NB.1.8.1 is surging in China, Hong Kong, and Taiwan.
New HHS Announcement Alters COVID-19 Vaccine Recommendations
Secretary Kennedy announced that the COVID-19 vaccine no longer would be recommended for healthy children or healthy pregnant women. He made the announcement in a video released on the social media platform X. Until recently, the vaccines had been recommended for everyone over 6 months of age. Now, it appears that the vaccine only will be recommended for children or pregnant women who have certain underlying conditions.
This policy change comes just a week after the FDA announced that the COVID-19 vaccine should only be offered to people over the age of 65 and people between the ages and 6 months and 64 years who have underlying conditions.
The impact of these changes on the availability of the vaccines is unclear. Currently, the vaccines are covered by most insurance plans, Medicare and Medicaid. If coverage changes because of the new HHS guidelines, then people who elect to get vaccinated may need to pay for the shots. A two-tiered system of access, and protection, could result.
Various Experts Have Criticized The Change
Medical groups quickly and forcefully criticized Kennedy’s announcement. In a statement released on Wednesday, the Society for Maternal-Fetal Medicine noted that it, “strongly reaffirms its recommendation that pregnant patients receive the COVID-19 vaccine.” Similarly, Dr. Steven J. Fleischman, president of the American College of Obstetricians and Gynecologists, wrote, “ACOG is concerned about and extremely disappointed by the announcement that HHS will no longer recommend COVID-19 vaccination during pregnancy.”
When asked about the change in policy, Dr. Jennifer F. Kawwass, Professor, Division Director and Medical Director of the Emory Reproductive Center, commented that, “Many viruses, such as flu and COVID, have been proven to be more dangerous to pregnant women and their fetuses compared to non-pregnant women. Vaccination, when available, is the most effective way to minimize maternal and fetal risk from these viruses.” Dr. Kawwass continued. “As a reproductive endocrinologist who meets patients before they are pregnant, I counsel all patients about the importance of vaccination before and during pregnancy.”
Food and Drug Administration commissioner Dr. Martin A. Makary stood next to Kennedy during his announcement, seemingly signaling his support. But just a week earlier, he co-authored an article published in The New Journal of Medicine in which he stated that pregnancy is an underlying medical condition that increases a person’s risk of severe COVID-19. Vaccination, one would assume, should be encouraged in this population to minimize the increased risks. This statement by the FDA commissioner appears to contradict the statement made by the HHS secretary.
The vaccines are safe and effective
Numerous studies have shown that the mRNA-based vaccines produced by Moderna and Pfizer and the protein-based vaccine produced by Novovax are safe and effective. These studies have been conducted in people of various ages, from as young as six months of age. Moreover, thorough evaluations of the vaccines in pregnant women have been conducted and confirm the safety and efficacy of the vaccines in this demographic.
Indeed, COVID-19 vaccination may be especially important for women who are pregnant. The vaccines obviously can provide the pregnant individual with increased protection. Perhaps more importantly, the vaccines also can provide protection to their newborns. According to the CDC, the hospitalization rate for COVID-19 in children is highest among infants less than six months old. Maternal vaccination, however, can provide much needed protection to these children.
Change In Vaccine Policy Occurs As New Variant Surges In Asia
Public health practitioners worry that Kennedy’s directive will decrease access to COVID-19 vaccines. This change occurs while a new variant is spreading rapidly in Southeast Asia. Cases in several countries, including Taiwan, are surging. The increase seems to be driven by a new variant, NB.1.8.1. Although the biology of this variant has not yet been thoroughly studied, its seemingly rapid spread in places like Taiwan could indicate that it is more transmissible than previous variants.
Several cases of COVID-19 associated with NB.1.8.1 have been detected in the U.S. Currently, its prevalence is low. But that could change quickly. Vaccination remains our best defense against this and all other existing variants. Changes in vaccine policy, such as those recently announced, could hinder our preparedness.
